about
Cellular ageing mechanisms in osteoarthritisNonproliferative and Proliferative Lesions of the Rat and Mouse Skeletal Tissues (Bones, Joints, and Teeth)Delivering Agents Locally into Articular Cartilage by Intense MHz Ultrasound.Effect of vitamin E on oxidative stress level in blood, synovial fluid, and synovial tissue in severe knee osteoarthritis: a randomized controlled studyComparison of glucose derivatives effects on cartilage degradation.Endogenous adenosine maintains cartilage homeostasis and exogenous adenosine inhibits osteoarthritis progression.Comparative Clinical Observation of Arthroscopic Microfracture in the Presence and Absence of a Stromal Vascular Fraction Injection for OsteoarthritisModification of osteoarthritis in the guinea pig with pulsed low-intensity ultrasound treatment.MicroRNAs and Autophagy: Fine Players in the Control of Chondrocyte Homeostatic Activities in Osteoarthritis.Hip osteoarthritis in dogs: a randomized study using mesenchymal stem cells from adipose tissue and plasma rich in growth factorsBiological aspects of early osteoarthritis.Racial differences in symptom management approaches among persons with radiographic knee osteoarthritis.Directed differentiation of induced pluripotent stem cells into chondrogenic lineages for articular cartilage treatment.Regulation and Role of TGFβ Signaling Pathway in Aging and Osteoarthritis JointsChondroitin and glucosamine in the management of osteoarthritis: an update.The effect of compressive loading magnitude on in situ chondrocyte calcium signaling.Endocannabinoids and acute pain after total knee arthroplasty.Effects of insulin-like growth factor-1 and dexamethasone on cytokine-challenged cartilage: relevance to post-traumatic osteoarthritis.Correlations between both the expression levels of inflammatory mediators and growth factor in medial perimeniscal synovial tissue and the severity of medial knee osteoarthritis.Polarization second harmonic generation microscopy provides quantitative enhanced molecular specificity for tissue diagnostics.Proteases involved in cartilage matrix degradation in osteoarthritis.Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage.Immortalisation with hTERT Impacts on Sulphated Glycosaminoglycan Secretion and Immunophenotype in a Variable and Cell Specific MannerTherapeutic Potential of Differentiated Mesenchymal Stem Cells for Treatment of Osteoarthritis.Hyaluronic Acid Suppresses the Expression of Metalloproteinases in Osteoarthritic Cartilage Stimulated Simultaneously by Interleukin 1β and Mechanical Load.Perturbation of nuclear lamin A causes cell death in chondrocytes.The PLE(2)NO self-management and exercise program for knee osteoarthritis: Study Protocol for a Randomized Controlled Trial.Inflammation and Joint Tissue Interactions in OA: Implications for Potential Therapeutic Approaches.Effectiveness and safety of tapentadol prolonged release with tapentadol immediate release on-demand for the management of severe, chronic osteoarthritis-related knee pain: results of an open-label, phase 3b study.Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers.Generation and characterization of ABT-981, a dual variable domain immunoglobulin (DVD-Ig(TM)) molecule that specifically and potently neutralizes both IL-1α and IL-1β.Effect of a glucosamine-based combination supplement containing chondroitin sulfate and antioxidant micronutrients in subjects with symptomatic knee osteoarthritis: A pilot study.Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysmDrug delivery strategies for cathepsin inhibitors in joint diseases.A robust diffusion tensor model for clinical applications of MRI to cartilage.Vitamin D, race, and experimental pain sensitivity in older adults with knee osteoarthritis.Standardized butanol fraction of WIN-34B suppresses cartilage destruction via inhibited production of matrix metalloproteinase and inflammatory mediator in osteoarthritis human cartilage explants culture and chondrocytes.Will arthritis gene therapy become a clinical reality?Serum Metabolite Profiles Are Altered by Erlotinib Treatment and the Integrin α1-Null Genotype but Not by Post-Traumatic OsteoarthritisTransplantation of Nonexpanded Adipose Stromal Vascular Fraction and Platelet-Rich Plasma for Articular Cartilage Injury Treatment in Mice Model.
P2860
Q26746549-1DA2C80A-B93D-4440-924C-7DF0CBFB3ECAQ28079465-D0B647ED-28B4-4E83-822A-58C59BB98120Q30402318-DFBF036B-50EA-4FFD-9FB7-17F84D1D7426Q32174010-2526D27E-C3D7-419F-8C02-153F75A734E0Q33632751-C5843359-9929-4687-8482-CB8C4105DB2EQ33705612-1EBE721C-0A90-472A-9A7F-9349334AF504Q33722152-199B4CF5-D847-4CDB-BF5F-5DE71DF041D9Q33865954-6E526FA5-C8C6-4F8E-B39E-648BD2F44CA2Q33872848-65DD17E1-0CCF-4081-B4B9-E0CB75F7DAE4Q34158368-1E11CE10-8212-498E-B17E-7AE9B4B27C36Q34225355-25ED2C52-877E-4CFC-8FCA-84E116A3E169Q34329389-75CB78B3-B6EA-4B4B-98BE-A7987681EA15Q34461122-FE3C7EA8-8C62-43D4-A1C8-D8C8E201274FQ34599321-9C33DC25-EBE5-4352-A54E-C0D0C88A902FQ34655436-50EAC49F-8A21-4404-8B3C-0548AF103BA3Q34807781-9369EF2E-F3FD-48A9-9EEE-8A7B9467C9D6Q34988278-CFC0AAF3-4A8A-415E-8FDD-5309DD63BA2DQ35007761-BCD47CB7-71DF-4F94-847C-8446C0B67A14Q35013171-01B59297-B396-46D5-A49F-6C7413F44305Q35386272-A0425D06-D758-440A-94B4-347E2C06EC29Q35560686-1CD8A44B-2E83-4EBF-B78B-0DE1A0CC9B53Q35605620-03AE37C0-9BA1-4007-94AE-090D84232BD5Q35702383-9FAC0C46-8707-4A9D-9175-4B2E47BEB426Q35902463-0B7F5DE3-3AB3-4536-BE47-5A0D1A598F76Q35943198-BF291414-9A05-4E0C-96EC-ED2F86B391BEQ35946912-B3BC22D3-F2D5-47C3-99B9-07B462518D61Q36042425-B02C64D3-A8EA-444C-B9EE-F6D73C8C9528Q36057665-C6CA095F-9F66-462C-9F9C-340232156326Q36085061-DC58F7E6-B80A-46DB-BD1F-D85DC3B40DBBQ36171138-0D404A76-74CB-440D-BB35-F7204B6633BCQ36213688-8274D3C6-609E-413D-BBC3-62772109ABACQ36230822-6EBF5CB0-8EA5-4680-9B48-EC50AE77FA0DQ36248775-473F0992-A9E6-4708-999E-EA2CBF3AAAB9Q36316921-84CE2229-0ECB-48C2-8FEC-4A8AA80F194FQ36384534-8D54F2A7-D6F4-4357-AA52-311BE1F29F44Q36434431-62685536-60CC-4CE2-A8F7-14F8C3A81FF0Q36574611-4CCD5948-B822-427B-8879-EA721EF79139Q36577512-C2457015-4410-4FED-8715-058F30226244Q36654870-23E0ADEE-DA9B-4B51-8B75-4889330F5B9EQ36663443-30D0AB02-6B12-40A6-93AA-C745A288D8A5
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Osteoarthritis - an untreatable disease?
@ast
Osteoarthritis - an untreatable disease?
@en
type
label
Osteoarthritis - an untreatable disease?
@ast
Osteoarthritis - an untreatable disease?
@en
prefLabel
Osteoarthritis - an untreatable disease?
@ast
Osteoarthritis - an untreatable disease?
@en
P2093
P356
P1476
Osteoarthritis - an untreatable disease?
@en
P2093
Bernhard J Kirschbaum
Heike A Wieland
Karl A Rudolphi
Martin Michaelis
P2888
P304
P356
10.1038/NRD1693
P577
2005-04-01T00:00:00Z
P6179
1013230240